Treatment of LCA5 gene-dependent LCA (type 5) is similarly advanced [54], while a so-called “molecular photoswitch”, conferring light-sensing capabilities to special types of retinal neuron cells, could potentially become a new treatment in RP and choroideremia [55]. Here, LCA5 is linked to choroideremia.